NERLYNX – Breast Cancer Treatment [transcript] [audio]

Guest: Frankie Ann Holmes, MD

Presenter: Neal Howard

Guests Bio: Dr. Holmes is board certified in internal medicine and also medical oncology. My professional career has involved the treatment and research for the cure of breast cancer. At MD Anderson, I completed my cancer training and joined the Faculty of Breast Medical Oncology. At MD Anderson, I performed the first clinical trial of paclitaxel (Taxol) resulting in approval for breast cancer. After 15 years at MD Anderson, I joined Texas Oncology/The US Oncology Network and the Breast Cancer Research Committee. I was the principal investigator for the clinical trial that led to the approval of pegfilgrastim (Neulasta) for prevention of low white blood cells from chemotherapy. I have continued as an active member of the Breast Cancer Research Committee with The US Oncology Network.

Segment overview: Frankie Ann Holmes, MD, discusses the latest in breast cancer research and the recently approved NERLYNX for early-stage HER2-positive breast cancer.

1 Comments

  1. Anyone that has worked with Frankie knows about her dedication to breast cancer clinical research. This dedication comes from a very genuine and personal desire to make a positive impact for her patients. I’ve been very fortunate to know some of the best medical oncologists in the country and Frankie Ann Holmes is among the best of the best. Congratulations to all involved in this drug approval…and especially to the patients that participated in the clinical trials.

Leave a Reply

You must be logged in to post a comment.